Revenue growth 10-15% for FY27
Management expects revenue to grow by 10-15% in FY27, driven by volume growth of around 15% and stable pricing.
Sharda Cropchem · forward-looking guidance across the available source record.
Guidance tracker
Management expects revenue to grow by 10-15% in FY27, driven by volume growth of around 15% and stable pricing.
Gross margins are expected to stay around 35% plus or minus a few percentage points, similar to FY26 levels.
EBITDA margins are guided to be in the range of 18-20% for FY27, down from 24.8% in Q4 but consistent with full-year FY26 levels.
The effective tax rate is expected to be between 18-20% for FY27, similar to recent trends.